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Hybridoma monoclonal antibodies are highly specific antibodies produced in large quantities by cloning a single hybrid cell formed by the fusion of a murine B cell and a tumor cell. Recent attempts to generate a monoclonal antibody against ricin have proven to be successful. Because ricin as a whole is extremely toxic, the B chain, which is non-toxic, was chosen to immunize the mice. The B chain selectively binds to residual groups of galactose present on membrane surfaces found within murine cells. It acts to induce the enclosure of ricin molecules in the B cells.
After a pre-determined immunization period, the murine spleens containing the B cells are harvested and fused together with a tumor cell (SP2/0) to generate the first round of monoclonal cells. Subsequent screenings are conducted using the enzyme linked immuno sorbent assay (ELISA) followed by additional cloning steps. The resulting cell lines are stable, monoclonal hybridomas.
The supernatant generated from the cell lines are protein purified and tested via ELISA for cross-reactivity and specificity. The final product is a hybridoma monoclonal antibody specific to the target for which it was originally immunized against.
Monoclonal antibodies currently produced and stored at the U.S. Army Edgewood Chemical Biological Center (ECBC) include Ricin B Chain, OVA, Abrin, Cholera Toxin B, Fowlpox, T-2 ,and Microcystin.
MATERIALS AND METHODS

Antigen (PBS)
Ricin Toxin B Chain Lyophilized RTB (1.0 mg: Vector) rehydrated in 1 mL phosphate buffered saline
Ovalbumin
Powder OVA (2.0 mg: Sigma) rehydrated in 1 mL PBS
Abrin Toxin
Lyophilized Abrin Toxin (1.0 mg: Toxin Technology Inc.) rehydrated in 1 mL PBS Female BALB/c mice were injected subcutaneously. Freund's incomplete adjuvant was always used except for the first injection when the antigen was emulsified in Freund's complete adjuvant.
Myeloma
The SP2/0-Ag 14 (SP2/0) myeloma cells were grown in ISCOVE Modified Eagle Medium (IMDM) supplemented with 10% heat-inactivated fetal bovine serum (FBS), 1% Penicillin/ Streptomycin, ImM Sodium Pyruvate, and 2mM L-Glutamine, at 37 °C in a 5.0% C0 2 water jacketed incubator.
Traditional Fusion
The SP2/0 cells in log phase of growth were harvested and pelleted via centrifugation at 3500 rpm for 5 min at room temperature. The cells were washed three times with RPMI-1640. The spleens were removed aseptically, and the cells were released by pressing the blunt end of a syringe plunger against a sterile petri dish. Debris was allowed to settle out of solution, and the cells were removed and placed into a fresh, sterile 50 mL conical tube. The red blood cells were lysed with sterile water and RPMI-1640. The suspension was centrifuged at 3500 rpm for 5 min, and the splenocytes were pelleted. The cells were washed three times with RPMI-1640.
The SP2/0 and splenocytes were counted and mixed at a ratio of 1:3 to 1:7 and were pelleted by centrifugation. Polyethylene glycol 1500 was added to the cells and gently stirred. The suspension was then diluted with RPMI-1640 and centrifuged at 3500 rpm for 5 min.
The cells were distributed into 96-well tissue culture plates in IMDM containing hypoxanthine, aminopterin, thymidine (IMDM-HAT) plus 1% Penicillin/Streptomycin, 2mM L-Glutamine, ImM Sodium Pyruvate, and 10% Bovine Growth Serum (BGS). The cells were kept at 37 °C in a 5% C0 2 water jacketed incubator.
2.5
Traditional Screening
All 96-well tissue culture plates were then assayed via ELISA 14 days after fusion. Polystyrene 96-well microtitre ELISA plates were coated with 100 uL of PBS containing 1 to 10 ug of the desired antigen and placed in a 4 °C refrigerator for 12-24 h. After four washes with 10X PBS and 10 mL Tween 20 (ELISA wash buffer), the plates were blocked for 1 h in a 37 °C incubator with 200 uL of 50 g skim milk dissolved in IX PBS. After four washes with ELISA wash buffer, the plates were incubated with 100 uL of hybrid supernatants for 1 h at 37 °C. After four washes with ELISA wash buffer, 100 uL of anti-mouse IgA + IgG + IgM (H+L) antibody conjugated with horseradish Peroxidase (HRP) (KPL) (1:3000 dilution in 50 g skim milk dissolved in IX PBS and lmL Tween 20) were added and incubated at 37 °C for 1 h. After four washes with ELISA wash buffer, 100 uL of substrate solution (1:1 dilution of ABTS Peroxidase Substrate Solution A and Peroxidase Substrate Solution B) were added and incubated for 30 min at 37 °C. The absorbances were read at 405 nm (A405 nm) with an ELx800• Absorbance Microplate Reader (BioTek) (see Table 1 ). The positive hybrids were subcloned once by the limiting dilution procedure in IMDM containing hypoxanthine and thymidine (IMDM-HT) plus 1% Penicillin/Streptomycin, ImM Sodium Pyruvate, 2mM L-Glutamine and 10% Bovine Growth Serum (BGS) to ensure monoclonality and stability of the cells. Clones were expanded by sequential transfer into 24-well tissue culture plate, 25 and 75 mL tissue culture flasks. The clones were frozen and stored at -195 °C.
2.7
Novel ClonaCell® -HY Fusion
The SP2/0 cells were harvested, counted, and resuspended at 2 x 10 7 viable cells. The splenocytes were obtained from a single spleen, counted, and resuspended at 1 x 10 x viable cells. The 2 x 10 7 SP2/0 cells and 1 x 10 8 splenocytes were combined in a 50 mL conical tube and centrifuged for 10 min at -1350 rpm and pelleted. Polyethylene glycol (PEG) was added to the cells and gently stirred. The suspension was then diluted with Medium B and incubated for 15 min. Medium A was slowly added to the suspension and centrifuged at -1350 rpm for 7 min to form a pellet. The pellet was resuspended in 10 mL Medium C and transferred to a T'75cm tissue culture flask containing 40 mL of Medium C. The fused cell culture was incubated for 16-24 h at 37 °C in a 5% CO2 water jacketed incubator.
Novel ClonaCell® -HY Selection and Cloning
The 16-24 h post fusion transferred the fused cell suspension to a 50 mL conical tube and centrifuge for 10 min at -1350 to form a pellet. The pellet was resuspended in 10 mL Medium C. The 10 mL cell suspension was transferred into 90 mL of Medium D and mixed completely by inverting the bottle several times. The suspension sat for 15 min at room temperature, allowing the bubbles to rise to the surface. 9.5 mL of the cell suspension were then aseptically plate out into 10 individual 100 mm petri plates. The plates were tilted to level the mixture. The plates were incubated for 14 days at 37 °C in a 5% CO2 water jacketed incubator.
2.9
Novel ClonaCell® -HY Harvest At 14 days post fusion; the plates were examined for visible colonies. The isolated colonies were removed from the plates and placed into individual wells of a 96-well tissue culture plate containing 200 uL of Medium E. the 96-well tissue culture plates were incubated at 37 °C, 5% C0 2 for 4 days without feeding.
2.10
Novel ClonaCell® -HY Screening
The same screening procedure was followed as in Section 2.5. Positive responses were transferred into 2 wells of a 24-well tissue culture plate, 100 uL each into 1 mL of Medium E. Once the cells reached a density of 4 x 10 5 cells/mL, one well was frozen and the other was transferred to a T'25cm 2 tissue culture flask with 5 mL of Medium A and 5 mL of Medium E. After the cells reached a density of 4 x 10 5 cells/mL, the culture was transfer to a T'75cm2 tissue culture flask containing 30 mL of Medium A.
2.11
Traditional Additional Cloning Step
An additional "traditional" cloning step was added to verify the stability of the clones. The positive hybrids from Section 2.10 were subcloned once by the limiting dilution procedure in IMDM-HT plus 1% Penicillin/Streptomycin, ImM Sodium Pyruvate, 2mM L-Glutamine, and 10% BGS to ensure monoclonality and stability of the cells. Clones were expanded by sequential transfer into 24-well tissue culture plates, 25 and 75 mL tissue culture flasks. The clones were frozen and stored at-195 "C.
RESULTS AND DISCUSSION
Thirteen hybridomas producing mAbs to various immunogens were selected on the basis of consistently producing positive ELISA results and excreting the desired IgGi (K) isotype (Table 2) . These hybridomas were cloned once and expanded. All 13 of these antibodies belonged to the IgG subclass. 
31.25% chance clones are monoclonal
The positive hybrids were expanded for protein purification where it was determined the clones were not monoclonal at the time of the initial selection and freezing. To correct this problem, all positive hybrids were expanded and subcloned an additional time by the limiting dilution procedure, which was now adopted from the Ricin-B Chain and Ovalbumin troubleshooting. The limiting dilution procedure was slightly modified to account for the rapidly growing cells. The 1/32 cpw was removed and 1/256 cpw was added.
By applying the probability theory, Poisson distribution, (Table 5) , we were able to calculate with certain confidence the clones have a high probability of being monoclonal. Lower probability = Higher confidence in monoclonality.
Clones were expanded by sequential transfer into 24-well tissue culture plates, 25 and 75 mL tissue culture flasks. The clones were frozen and stored at -195 °C. 
Abrin Toxin and Toxoid
The positive hybrids were subcloned twice by the limiting dilution procedure in IMDM-HT plus 1% Penicillin/Streptomycin, ImM Sodium Pyruvate, 2mM L-Glutamine and 10% BGS to ensure monoclonality, and stability of the cells. Clones were expanded by sequential transfer into 24-well tissue culture plates, 25 and 75 mL tissue culture flasks. The clones were frozen and stored at -195 °C.
The supernatant from the positive hybrids were purified to determine if the clones were monoclonal or needed to undergo further selection.
The cell lines produced were extremely slow growing but stable.
14
Fowlpox Virus
Due to the lack of a positive control antibody at the time of the fusion, the fusion was performed and at 14 days post fusion, the cells were harvested and frozen at -195 °C. A positive control antibody was subsequently obtained and tested on the immunogen. The results were disappointing and indicated a failure. It is believed that the storage of the virus was improper, which lead to the lack of an immune response in the mice. Further testing has been postponed at this time.
4.5
T2-OVA and T2-BSA The T2-OVA cells did not grow and were subsequently deemed a failure. Further testing of T2-OVA has been postponed at this time.
The T2-BSA positive hybrids were subcloned twice by the limiting dilution procedure in IMDM-HT plus 1% Penicillin/Streptomycin, ImM Sodium Pyruvate, 2mM L-Glutamine and 10% BGS to ensure monoclonality, and stability of the cells. Clones were expanded by sequential transfer into 24-well tissue culture plates, 25 and 75 mL tissue culture flasks. The clones were frozen and stored at -195°C.
The supernatant from the positive hybrids will be purified to determine if the clones are monoclonal or need to undergo further selection.
The cell lines produced are extremely slow growing but stable.
4.6
Microcystin LR-BSA
A new fusion protocol was tested to see if monoclonality could be reached at a quicker rate and still maintain the same quality product. The ClonaCell® -HY Hybridoma Cloning Kit from StemCell Technologies (Vancouver, BC) was tested and proven to be successful.
The supernatant from the positive hybrids will be purified so that characterization and down selection can commence.
